9,198
Total Claims
$576K
Drug Cost
1,063
Beneficiaries
$542
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-49%
Cost per patient vs peers
$542 vs $1,068 avg
Brand vs Generic
91% generic
Brand: 826 claims · $429K
Generic: 8,337 claims · $145K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 46 | $76K |
| Apixaban | 39 | $56K |
| Empagliflozin | 42 | $54K |
| Sitagliptin Phosphate | 27 | $35K |
| Dulaglutide | 24 | $22K |
| Fluticasone Propion/Salmeterol | 26 | $17K |
| Insulin Aspart Prot/Insuln Asp | 14 | $16K |
| Budesonide/Formoterol Fumarate | 24 | $13K |
| Atorvastatin Calcium | 823 | $12K |
| Levothyroxine Sodium | 595 | $7,758 |
| Levothyroxine Sodium | 101 | $7,064 |
| Pravastatin Sodium | 378 | $6,605 |
| Rosuvastatin Calcium | 381 | $6,464 |
| Fluticasone Propionate | 11 | $5,091 |
| Ezetimibe | 115 | $4,595 |
Prescribing Profile
Patient Profile
74
Avg Age
62%
Female
0.95
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data